High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients

Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to FGFR inhibitors. The aim of this study was to investigate the frequency and the prognostic impact of FGFR1 amplification in patients with resected esophageal squamous cell carcinoma (ESCC) by using fl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Song, Qi, Liu, Yalan, Jiang, Dongxian, Wang, Haixing, Huang, Jie, Xu, Yifan, Sujie, Akesu, Zeng, Haiying, Xu, Chen, Hou, Yingyong
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650361/
https://ncbi.nlm.nih.gov/pubmed/29088806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20215
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky